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Abstract
Background: Dysfunctional cognitions and attitudes about sleep are considered as one of the most important factors underlying
insomnia.
Objectives: The current study aimed at investigating the validity and reliability of the dysfunctional beliefs and attitudes about
sleep scale-10 (DBAS-10) in an Iranian clinical population.
Methods: The clinical sample consisted of 120 patients with insomnia disorder referred to the sleep disorders clinic at Baharloo
hospital in Tehran in 2015. The control group (n = 120) included a community sample volunteered to participate in the study. Sleep
Diary, Pittsburgh Sleep Quality Index, Insomnia Severity Index, Pre-Sleep Arousal Scale, and Depression, Anxiety, Stress Sacle-21, were
used to assess concurrent validity. Test-retest and Cronbach’ alpha were conducted to examine the reliability of the scale. Construct
validity of the scale was investigated via confirmatory factor analysis.
Results: The current study findings indicated that DBAS-10 had appropriate test-retest reliability (r = 0.83) and internal consistency
(Cronbach’ alpha = 0.82). Total score of DBAS-10 was significantly associated with PSQI (r = 0.34), ISI (r = 0.45), the cognitive subscale
of PSAS (r = 0.36), and depression (0.34), anxiety (r = 0.34) and stress (r = 0.39) subscales of DASS-21. Factor analysis indicated that the
Espie et al. (2000) model had significantly better fitness in comparison with the Edinger and Wohlgemuth (2001) model. The cutoff
point, sensitivity, and specificity of the scale were 6.7%, 74.17% and 87.50%, respectively.
Conclusions: The Persian version of DBAS-10 had proper psychometric properties for Iranian clinical population.
Keywords: Attitude, Mental Health, Psychometrics, Sleep
1. Background
Insomnia includes difficulty with initiation or main-
tenance of sleep or early morning awakening associated
with significant distress or clinical disturbance (1). It is as-
sociated with major problems in different domains such
as physical (e.g. hypertension), occupational (e.g. job loss),
and mental health (e.g. depression) (2). Many studies
showed that insomnia is more prevalent in females rather
than males (3). Gender differences in insomnia could be at-
tributed to many factors such as psychiatric problems, so-
cial and cultural factors, symptom endorsement, and cop-
ing strategies (3).
Among different factors underlying insomnia, dys-
functional cognition and attitudes toward sleep are con-
sidered as one of the most important ones (4). Conse-
quently, assessment of these unhelpful cognitions and
challenging them are important interventions in cogni-
tive behavior therapy for insomnia (CBT-I) (5).
DBAS-10 is a self-monitoring measure that can be used
for assessment and therapeutic purposes: the assessment
of dysfunctional cognitions and planning cognitive ther-
apy sessions for insomnia (6, 7). The original version of
DBAS was designed based on the theoretical conceptualiza-
tion and clinical practice related to insomnia. It comprises
30 items and 5 subscales including: 1. “misconceptions
about the causes of insomnia”; 2. “misattributions or am-
plifications of its consequences”; 3. “unrealistic sleep ex-
pectations”; 4. “control and predictability of sleep”; and, 5.
Copyright © 2018, Iranian Journal of Psychiatry and Behavioral Sciences. This is an open-access article distributed under the terms of the Creative Commons
Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in
noncommercial usages, provided the original work is properly cited.
Doos Ali Vand H et al.
“faulty beliefs about sleep promoting practices” (6). The re-
vised version of the scale entitled “Personal Beliefs and Atti-
tudes about Sleep Scale” includes 28 items and 5 subscales
(consequences, control/ predictability, unrealistic expecta-
tions, causal attributions and sleep-promotion practices)
(8). In the new version, the wording of some of the sen-
tences is changed. Items 7 and 26 are removed. The reliabil-
ity of the 2 subscales, unrealistic expectations, and faulty
attributions are reported to be low (8). Overall, the sub-
scales suggested by Morin are supported only by a few fac-
tor analysis studies (9, 10).
The 16-item version of the scale was designed later (11).
The factor structure of the 16-item version is similar to that
of the 30-item version and measures 4 factors; i e, “per-
ceived consequences of insomnia”, “worry or helplessness
about sleep”, “expectations related to sleep”and “medica-
tion”. The 16-item version showed reasonable reliability
and validity in research and clinical populations (11).
Espie et al. identified 10 items of DBAS that were highly
sensitive to cognitive-behavioral therapy. Principal com-
ponent analysis (PCA) indicated 3 factors for the 10-item
scale (DBAS-10): beliefs about the immediate negative con-
sequences of insomnia, beliefs about the long-term nega-
tive consequences of insomnia, and beliefs about the need
to control insomnia (9). The study showed that DBAS-10
had a more robust principal component in comparison
with DBAS-30 (9). Edinger and Wohlgemuth also exam-
ined the psychometric properties of DBAS-10. Their study
showed that the 10-item version of scale had acceptable in-
ternal consistency and significant association with the 30-
item version, and had the ability to distinguish between
individuals with normal sleep and insomnia. In addi-
tion, using orthogonal, Varimax rotation method, 3 DBAS-
10 subscales were identified, which were somewhat differ-
ent from those of the previous findings (12).
In Iranian populations, the scale was standardized
among college students and the results confirmed the
good internal consistency and test-retest reliability of the
scale (13). Nevertheless, psychometric properties of the
scale are not examined in any Iranian patient populations.
2. Objectives
The current study aimed at examining the psychomet-
ric properties of the DBAS-10 in an Iranian clinical popula-
tion. To the authors best knowledge, no confirmatory fac-
tor analysis is conducted with regard to the factor struc-
ture indicated by the 2 previous studies (9, 12). Therefore,
the first important aim of the current study was to retest
the proposed factor structure of DBAS-10. Moreover, no
study examined the validity and reliability of the DBAS-10
in clinical population of Iran. If it is shown that the scale
has satisfactory reliability and validity in a clinical popula-
tion, it can then be used by researchers and clinicians in or-
der to assess dysfunctional beliefs about sleep and evaluate
the outcome of CBT-I studies in an Iranian clinical popula-
tion. Also, no study examined the cutoff point, sensitivity,
and specificity of the DBAS-10. By developing cutoff points
for DBAS-10, it can be used as a screening tool to detect indi-
viduals with significant dysfunctional beliefs about sleep.
The study also aimed at assessing the effect of gender dif-
ferences on DBAS-10 total score. In general, the current
study aimed at validating the Persian version of DBAS-10
in an Iranian clinical population. It was expected that the
psychometric properties of DBAS-10 (validity and reliabil-
ity) would be confirmed. Further, it was expected that the
Persian version of DBAS-10 would indicate possible gender
differences.
3. Materials andMethods
3.1. Participants
The 120 patients with insomnia disorder were re-
cruited from Sleep Disorders Clinic of Baharloo hospital in
Tehran from April to October 2015. The DSM-V criteria for
insomnia disorder (sleep latency or waking after sleep on-
set more than 30 minutes, which occurs 3 times per week,
lasting for at least 3 months and makes clinically signif-
icant distress) and score above 5 in the Pittsburgh Sleep
Quality Index (PSQI) were considered as the inclusion cri-
teria. Since DSM-V does not differentiate primary insom-
nia from insomnia secondary to medical and psychiatric
condition or other sleep disorders, all types of insomnia
regarding DSM-V criteria were included in the study. Ex-
clusion criteria were the use of medication known to affect
sleep and evidence of significant cognitive impairment (e
g, dementia).
The control group consisted of 120 normal sleepers
who responded to the study recruitment advertisements
and met research diagnostic criteria for normal sleepers
(14). They did not complain about sleep or daily symp-
toms of insufficient sleep, had a regular sleep/wakefulness
schedule, did not have any evidence of medical conditions
or psychiatric disorders disturbing sleep, primary sleep
disorder, and sleep disturbance due to substance intoxi-
cation or withdrawal. Furthermore, they agreed with the
statement that “I am a good sleeper” and had a score lower
than 5 in PSQI.
Out of the total patient sample, 30 participants com-
pleted the DBAS-10 twice with a 3-week interval for test-
retest reliability purposes. The test-retest subsample (33.3%
males, 30% single) had a mean age of 33.3 years old, and
were recruited randomly from the patient participants.
This subsample was included in the main study analyses.
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3.2. Measures
3.2.1. Dysfunctional Beliefs and Attitudes About Sleep Scale-10
The DBAS-10 (9) is a short-form of DBAS-30 (8) that as-
sesses dysfunctional cognitions about insomnia. The items
of DBAS-10 were chosen considering their changes before
and after cognitive behavior therapy (9). The items are re-
sponded based on a 10-point visual analogue scale (VAS)
(0 = completely disagree, 10 = completely agree). The re-
sults of previous studies showed an internal consistency
of .69 and its ability to distinguish between normal sleep-
ers and insomniacs. Factor analysis confirmed that DBAS-
10 consisted of 3 factors (9). Internal consistency and test-
retest (with a 2-week interval) reliability of DBAS-10 in an
Iranian college student population were 0.84 and 0.83, re-
spectively (13).
3.2.2. Insomnia Severity Index
ISI (7) is a 7-item self-report measurement designed to
assess individuals’ perception of sleep. ISI measures diffi-
culties with initiation and maintenance of sleep, satisfac-
tion with current pattern of sleep, interference with daily
functioning, noticeability of the disturbance attributed to
sleep problems, and level of distress or worry due to sleep
problems. ISI is responded on a 5- point Likert scale (0 =
never, 5 = very much). The score ranges from 0 to 28. The
Internal consistency of ISI was 0.74 and contains 3 factors:
effect, intensity, and satisfaction (15). ISI had proper psy-
chometric properties among Iranian clinical populations
(Cronbach’ alpha = 0.82, correlation coefficient of item-
total ranging from 0.56 to 0.91.) (16).
3.2.3. Pittsburgh Sleep Quality Index
PSQI (17), a 19-item inventory, measures 7 components
of the quality of sleep (i e, subjective quality of sleep, sleep
latency, duration, efficiency, disturbances, use of sleep
medication, and daily dysfunction in performance). Each
component is rated on a scale from 0 to 3. PSQI scores
range 0 to 21 with a cutoff point of 5, which discrimi-
nates bad sleepers from good ones. PSQI has good internal
consistency (α = 0.83) and test-retest reliability (r = 0.85).
The sensitivity and specificity of PSQI were reported 89.6%
and 86.5%, respectively (17). The Persian version of PSQI
was studied in Iranian populations and the observed Cron-
bach’ alpha for patients and control groups were 0.52 and
0.78, respectively. Furthermore, it had appropriate sensi-
tivity and specificity (94% and 72%, respectively) and was
correlated with the general health questionnaire-12 (GHQ-
12; r = 0.54) (18).
3.2.4. Pre-Sleep Arousal Scale
PSAS (19), with 16 items, was designed to evaluate so-
matic and cognitive aspects of arousal. It is answered on
a 5-point Likert scale. The scale, with the ability to distin-
guish individuals with insomnia from those with normal
sleep, showed good internal consistency (α= 0.76 for phys-
ical subscale and α = 0.84 for cognitive subscale) (19). The
validity and reliability of PSAS were investigated among 30
Iranian college students. Internal consistency of the total
scale, somatic, and cognitive subscales were 0.85, 0.84, and
0.72, respectively. Test-retest reliability (with a 2-week in-
terval) for total score, cognitive, and somatic subscales was
0.88, 0.86 and 0.93, respectively (20). In the current study,
cognitive subscale of PSAS (PSAS-C) was used to assess the
convergent validity of DBAS-10.
3.2.5. Depression, Anxiety and Stress Scale-21
DASS (21) is used to assess negative affectivity (depres-
sion, anxiety, and stress). Previous studies showed that
DASS-21 was psychometrically sound with reliability coef-
ficients of 0.82, 0.90, and 0.93 for depression, anxiety and
stress, respectively (22). The Persian version of DASS-21 ex-
hibited good internal consistency (Cronbach’s alpha 0.75
- 0.87) and test-retest reliability (0.78 - 0.81) in an Iranian
population (23).
3.3. Sleep Diary
SD is a self-report measurement, providing informa-
tion about the pattern and quality of sleep from one night
to another. SD may collect sleep-related information for
several weeks. The principal variables assessed by SD
(24) consist of total time spent in bed (TIB), total actual
sleep time (TST), sleep onset latency (SOL), early morning
awakening (EMA), total time of wakening after sleep on-
set (WASO), and sleep efficiency (SE). A study conducted by
Lichstein et al. revealed a significant association between
sleep diaries and polysomnography, on WASO, SE, and TST
(25). In the current study, the participants were asked to
complete the SD for 2 weeks.
3.4. Considerations
The study was approved by the ethical committee of
the Tehran University of Medical Sciences (code: 92-03-178-
24607-264321). Written consent was obtained from all par-
ticipants. Participants were informed that their participa-
tion was voluntary and that they could discontinue at any
time.
3.5. Statistical Analysis
The structural equating modeling (26) was used to
evaluate the measurement model fitness using confirma-
tory factor analysis (CFA) (27) (Table 1). All standardized fac-
tor loadings and indicator t values were larger than 0.4 and
2.58, respectively. The fit of the model is assessed using the
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following goodness-of-fit indices (28): χ2 which is very sen-
sitive to sample size and non-normality of the data. A non-
significant χ2 implies the goodness-of-fit of the model to
the data; RMSEA (the root mean square error of approxi-
mation) is a fit measure based on population error of ap-
proximation. A RMSEA value below 0.08 indicates a close
fit and values below 0.10 represent reasonable errors of ap-
proximation in the population; CFI that is a comparative
fit index and represents the proportionate improvement
in model fit by comparing the target model with a base-
line model, and non-normed fit index (NNFI). In the cur-
rent study, goodness-of-fit was evaluated using the follow-
ing statistics: NNFI, CFI, and AGFI (adjusted goodness of fit
index) higher than 0.90; normal chi-square (normed-chi-
square (NC: less than 2) (29); SRMR and RMSEA and its 90%
confidence interval (< 0.08) (30).
In addition, the internal consistency of the DBAS-10 and
its subscales was examined using Cronbach’s alpha. The
convergent validity was evaluated by examining the cor-
relations between the DBAS-10, ISI, PSQI, and PSAS-C scores.
In addition, mean inter-item correlation coefficients were
computed for DBAS-10. Given the number of correlations
and comparisons, the P values were adjusted based on Bon-
ferroni procedure: an initial α of 0.05 was divided by the
number of measures (Table 2).
3.6. Procedure
The previous translated version of the DBAS-10 was
used in the current study (13). Participants were asked
to complete the DBAS-10, ISI, PSQI, PSAS-C, DASS-21, and SD
scales.
The participants were interviewed by the sleep
medicine specialists. All measures were administered
by trained clinical psychologists; 130 individuals were
originally invited to participate in this study, and 120
accepted the invitation to take part (92% response rate).
4. Results
The mean age of the patient group (44.2% male) was
43.30 years old (range: 17 - 70). They were predominantly
married (77.5%) and the majority of them had completed
secondary school (62.7%). Participants’ occupational sta-
tus was reported as housewife (54%), employee (43.7%), and
student (2.3%). The average TST,TIB and SE as computed
from the sleep diary was 4.1 hours, 7.8 hours, and 52.5%,
respectively. The mean insomnia duration was 9.19 years
(SD = 9.79) with a mean age of insomnia onset of 33.89
years (SD = 13.98). The mean age of the normal group (41.8%
male), was 37.6 years old (age range: 17 - 74). Of this sample,
36.4% were single and 41.8% completed secondary school.
In terms of occupational status, 41% reported being work-
ing, 48.5% being at home or retired, and 10.5% being stu-
dent.
4.1. Data Screening and Cleaning
Due to the fact the missing data ratio was less than 3%,
list-wise deletion with no imputation of data was used. The
assumption of normality was violated in most items skew-
ness > 2; kurtosis > 7) (31), and no transformation was per-
formed due to the large sample size (32). Regarding non-
normality of data and large sample size, a robust weighed
list squares (RWLS) estimation method was employed as it
is less sensitive to the lack of normality of ordinal data.
4.1.1. Aim 1: Factor Structure of DBAS
The results of the fit estimates for all models are pre-
sented in Table 1. The one-factor model (M1) and the 3-factor
orthogonal model (M2) did not meet the previously speci-
fied fit criteria; and the 3-factor oblique model (M3), and
the 3-factor oblique and correlated errors model (M4) were
adequately fit to the data. M3 was proposed by Espie et al.
and M4 was a modification of M3 by freed error covariance.
The chi-squared test was not significant for the 2 mod-
els (M4 and M3). The χ2 statistic is sensitive to sample
size (33) and affected by the size of the correlations in
the model (34); therefore, an evaluation of fitness indexes
among the nested models showed that the modified Espie
et al. model, namely 3-factor and correlated errors oblique
model (M4; Table 1), was significantly better than the 3-
factor oblique model (M3; Dχ2 = 12.32; Ddf = 2, P < 0.01).
It means that modifying the Espie et al. model by free er-
rors showed good improvements (M4; RMSEA < 0.05). In a
comparison between the nested models, Dχ2 revealed that
the 3-factor oblique and correlated errors model provided
a better fit [M4; S-B χ2/df = 1.19; CFI = 0.98; NNFI = 0.97; and
RMSEA = 0.044 [90% confidence interval (CI) = 0.01 - 0.087].
In addition to the Espie et al. model, Table 1 also
presents the results of the fit estimates for a 3-factor
oblique model (M5) and its modification (M6), as reported
by the Edinger et al. model. The chi-squared test was not
significant for the 2 mentioned models. An evaluation of
fitness indexes showed that 3-factor oblique and correlated
errors model (M6; Table 1) was significantly better than the
3-factor oblique model (M5; Dχ2 = 15.66; Ddf = 2, P < 0.001).
As Dχ2 revealed, the 3-factor oblique and correlated errors
model provided a better fit [M6; S-B χ2/df = 1.40; CFI= 0.96;
NNFI = 0.94; and RMSEA = 0.064 (90%CI = 0.01, 0.11]. The
fitness of the 2 modified models (M4 and M6) was com-
pared. As shown in Table 1, an evaluation of fitness indexes
among the 3-factor oblique models proposed by Espie et
al. and Edinger et al. after modification by freeing error
covariance (M4 and M6) showed that M4 (Table 1) had sig-
nificantly better fitness regarding the parsimony principal
(Dχ2 = 6.31; Ddf = 1, P < 0.01). In addition, although the dif-
ference between models 4 and 6 was somewhat small and
vague, both of them had the equal AIC and ECVI. Therefore,
model 4 i e, the Espie et al. model was more parsimonious
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Table 1. Parameter Estimates and Goodness-of-Fit Indices for DBAS-10, a
Items Based on the EspieModel P.E1 Z P.E2
Beliefs about the immediate negative consequences
of insomnia
1-Need 8 hours of sleep (factor3) .51 -5.9 .59
2-Need to catch up on sleep loss (factor3) .37 -1.01 .40
6-Insomnia interferes with daytime functioning
(factor1)
.76 -3.66 .75
7-Mood disturbances due to insomnia (factor1) .65 -2.89 .64
9-Lack of energy due to poor sleep (factor1) .74 -3.09 .76
Beliefs about the long-termnegative consequences
of insomnia
3-Consequences of insomnia on health (factor2) .40 -5.53 .52
5-Worried about losing control of sleep (factor2) .61 -3.01 .64
8-One poor night disturbswholeweek (factor2) .52 -1.13 .52
Beliefs about the need for control over insomnia
4-Trying harderwill lead to sleep (factor3) .40 -2.32 .27
10-No control over nocturnal thoughts (factor2) .57 -2.06 .55
Model ECVI NNFI SRMR RMSEA AGFI CFI AIC S-Bχ2 df NC
M1 3.50(2.96-4.12) .14 .26 .251 (.23 - .28) .48 .14 342.88 322.88 45
M2 1.46(1.19-1.81) .73 .20 .14 (.11 - .17) .70 .79 143.09 103.09 35 2.94
M3 .95 (.81-1.19) .93 .071 .071 (.020 - .111) .83 .95 93.99 47.99 32 1.50
M4(a) .87 (.82-1.70) .97 .068 .044 (.01 - .087) .86 .98 85.67 35.67 30 1.19
M5 1.06 (.88-1.32) .89 .084 .09 (.051 - 1.13) .80 .92 103.64 57.64 32 1.80
M6(a) .94 (.82-1.15) .94 .077 064 (.01 - .11) .83 .96 91.98 41.98 30 1.40
Abbreviations: a, diagonal error covariance which freed between items including 8 - 5, and 6 – 2; AGFI, adjusted goodness of fit index; AIC, the Akaike information criterion;
CFI, comparative fit index; M1, 1-factor model; M2, 3-factor orthogonal model; M3, the Espie et al. 3-factor oblique model; M4, correlated errors model to modifying M3; M5,
the Edinger et al. 3-factor oblique model; M6, correlated errors model to modifying M5, NC, normed-chi-square; NNFI, non-normed fit index; P.E1, parameter estimation
for the 3-factor Espie et al. model; P.E2, parameter estimation for the 3-factor Edinger et al. model; RMSEA, root mean square error of approximation; SRMR, standardized
root mean square residual; Z, Z score for tests of univariate normality.
aValues inside the parenthesis are the assigned items into the 3-factor Edinger et al. model.
than model 6, which had an improved goodness-of-fit to
offset the reduction of parsimony by 1, hence, selected as
the optimal model (35).
4.1.2. Aim2: Reliability, Convergent and Discriminant Validity of
DBAS-10
The DBAS-10 demonstrated a moderate internal consis-
tency with the patient group (Cronbach’ alpha = 0.82) in-
dicating satisfactory temporal stability of the scale. Out
of the total patient sample, 30 participants completed the
DBAS-10 twice with a 3-week interval to measure the test-
retest reliability. The test-retest subsample (33.3% male,
30% single) had the mean age of 33.3 years old, and were
recruited randomly from the patient participants. The re-
sults showed a significant correlation coefficient between
the 2 administrations (r = 0.83, P < 0.01).
To examine convergent validity, the DBAS-10 total score
was compared with those of ISI, PSQI, PSAS-C, and sleep di-
ary variables. The Pearson correlation coefficients between
the study variables are demonstrated in Table 2. As shown,
DBAS-10 significantly correlated with the total score of ISI
(P < 0.01), PSQI (P < 0.01), and PSAS-C (P < 0.01). Also, cor-
relation coefficients between DBAS-10 and the subscales of
DASS (depression, anxiety, and stress) were statistically sig-
nificant (P < 0.01). In addition, the results indicated a sig-
nificant correlation between DBAS-10 and sleep efficiency
(P < 0.01), and DBAS-10 and SOL (P < 0.05).
To test the discriminant validity of DBAS-10, the inde-
pendent samples t test was used. The results showed that
DBAS-10 discriminated subjects with insomnia from nor-
mal sleepers (t = 10.51, P < 0.001). Moreover, the results indi-
cated that all 3 subscales of DBAS-10 i e, beliefs about the im-
mediate negative consequences of insomnia (t = 5.49, P <
0.001), beliefs about the long-term negative consequences
of insomnia (t = 13.52, P < 0.001) and beliefs about the need
for control over insomnia (t = 7.69, P < 0.001) significantly
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Table 2. Correlations of DBAS-10 With ISI, PSQI, and DASS Subscales and PSAS-C
SD M Inter-Item
Correla-
tion
α 1 2 3 4 5 6 7 8 9 10 11 12 13 14
1-
Immediate
conse-
quences
1.14 39.28 .43 .79 1 .56a .36a
2-Long
conse-
quences
6.80 22.60 .32 .58 1 .53a
3-Need for
control
5.80 13.95 .30 .46 1
4-DBAS-10 1.97 75.83 .32 .82 1
5-ISI .45a 1
6-PSQI .34a .54a 1
7-
Depression
.34a .34a .23a 1
8-Anxiety .34a .38a .24a .68a 1
9-Stress .39a .42a .36a .76a .75a 1
10-PSAS-C .36a .38a .30a -.50a .52a .60a 1
11-SE -.31a -.37a -.52a -.15 -.18 -.29a -.08 1
12-SOL -.24b .22b .30a .12 .04 .11 .08 -.30a 1
13-WASO -.00 -.05 .08 .09 .13 .05 .11 -.19 .03 1
14-EMA -.18 -.05 .00 -.15 .04 -.02 .09 .12 -.09 -.08 1
Abbreviations: DASS, depression, anxiety, stress scale; DBAS-10, dysfunctional beliefs and attitudes about sleep scale-10; EMA, early morning awakening; ISI, insomnia
severity index; PSAS-C, pre-sleep arousal scale, cognitive subscale; PSQI, Pittsburgh sleep quality index; SE, sleep efficiency; SOL, sleep onset latency; WASO, total time of
awakenings after sleep onset.
aP < 0.01 (2-tailed).
bP < 0.05 (2-tailed).
discriminated patient group from the control group.
4.1.3. Aim3: Sensitivity and Specificity of DBAS-10
The ROC curve, which plots sensitivity versus speci-
ficity for every possible cutoff point, was obtained. The
Youden index was used to evaluate the optimal cutoff point
(sensitivity + specificity-1.00). Sensitivity and specificity in-
dices were calculated for all the possible DBAS-10 cutoff
points. The ROC curve was calculated to estimate the dis-
criminant capability of the instrument. The DBAS-10 raw
scores were analyzed to classify both at-risk and not-at-risk
groups. The best DBAS-10 cutoff point was 6.7 with a sensi-
tivity of 74.17% and a specificity of 87.50%, indicating that
12.50% of the not-at-risk group and 74.17% of the at-risk
group exceeded the cutoff of 6.7. The area under the curve
was 0.85 [(95% CI) = 0.79 to 0.89, P < 0.001].
4.1.4. Aim 4: Gender and Dysfunctional Beliefs About Sleep
Independent-samples t test was used to examine gen-
der differences in DBAS-10 score and its subscales. The re-
sults showed no significant differences between males and
females in DBAS-10 total score (t = -1.32, P = 0.18). Moreover,
no gender difference was observed in subscale 1 (t = -0.475,
P = 0.63), subscale 2 (t = 0.046, P = 0.96), and subscale 3 (t =
-0.308, P = 0.75) scores.
5. Discussion
The current study aimed at investigating the psycho-
metric properties of the Persian version of DBAS-10 in an
Iranian clinical population.
The main objective of the study was to further investi-
gate the factor structure previously proposed by Espie et al.
and Edinger and Wohlgemuth. The results showed that the
Espie model had significantly better fitness in comparison
with that of the Edinger and Wohlgemuth model. In the
study by Espie et al. three factors including beliefs about
the immediate negative consequences of insomnia, (1, 2,
6, 7, 9), beliefs about the long-term negative consequences
of insomnia, (3, 5, 8) and beliefs about the need for con-
trol over insomnia (10, 4) were identified (9). Edinger and
Wohlgemuth studied 69 individuals with normal sleep
and 142 ones with insomnia. They reported 3 emergent fac-
tors (factor one = items 6, 7, 9; factor 2 = items 3, 5, 8, 10;
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factor 3: items 1, 2, 4) (12). To explain, the sample of Edinger
and Wohlgemuth included middle-aged and old-aged in-
dividuals while Espie et al. studied adults selected for out-
patient treatment of chronic insomnia. The current study
was performed on a more extended age range, which was
more similar to that of the study by Espie et al. In general,
the results obtained by the current study confirmed the 3-
factor model proposed by Espie et al. and offered more ev-
idence to their model.
The analyses provided support that the Persian version
of DBAS-10 was a reliable scale during time with test-retest
reliability of 0.83. Besides, the results showed that the Per-
sian version of DBAS-10 was a measure with appropriate in-
ternal consistency (Cronbach’s alpha of 0.82) among Ira-
nian clinical populations.
The correlation between DBAS-10 and the total score of
ISI and its subscales including effect, intensity, and satisfac-
tion were significant, which provided evidence for the re-
lationship between dysfunctional cognitions about sleep
and an increase in the intensity of insomnia. The relation-
ship between DBAS and subscales of ISI is not studied to
date. Nevertheless, this correlation showed that dysfunc-
tional cognitions and attitudes about sleep were associ-
ated with the levels of interference of sleep difficulties with
daily function, intensity of problems with the initiation
and maintenance of sleep and early morning awakening,
reduced satisfaction with sleep pattern, and distress level.
In addition, partial correlation between DBAS-10 and PSQI
means that dysfunctional cognitions about sleep may be
related to the quality of sleep in individuals with insomnia.
Another important result of the study was statistically
significant association between DBAS-10 and DASS-21. In
spite of the significant relationship between DBAS-10 and
subscales of DASS-21, mild correlation coefficients suggest
that DBAS-10 assesses a construct distinctive of depression,
anxiety, and stress, which in turn is confirmative of diver-
gent validity of DBAS-10.
The significant relationship between DBAS-10 and PSAS-
C showed that the increase in cognitive arousal was related
to dysfunctional beliefs about sleep. In general, moder-
ate correlations between ISI, PSQI, PSAS, and DBAS-10 are in-
dicative of appropriate convergent validity of DBAS-10 in
an Iranian clinical population.
To the best of the authors‘ knowledge, the cutoff point,
sensitivity, and specificity of DBAS-10 are not investigated
to date. The current study provided support for the ability
of DBAS-10 to differentiate individuals with insomnia dis-
order from individuals with normal sleep. Hence, the Per-
sian version of DBAS-10 had proper discriminative validity
and acceptable sensitivity and specificity.
With regard to gender, the results of the current study
showed no significant difference in DBAS and its subscale
scores between the 2 genders. A meta-analysis of 31 studies
showed that insomnia significantly affected females more
than males (36). Although several studies examined gen-
der differences regarding insomnia, no study evaluated it
with regard to dysfunctional beliefs about sleep. The find-
ings of the current study suggested that dysfunctional be-
liefs about sleep were not related to a specific gender.
5.1. Limitations and Future Directions
The current sample comprised of adults living in a
large urban area. Thus, first of all, generalizing these find-
ings to other age groups or to Iranian adults living in the
countryside should be done cautiously. Second, consider-
ing the lack of standardized structured diagnostic inter-
view of sleep disorders in the Persian language, the par-
ticipants were only selected through diagnostic interviews
conducted by sleep specialists and other self-report mea-
sures, and no structured interviews unique to sleep disor-
ders were held with participants. Third, the current study
was cross sectional and no causal relationship can be con-
cluded from the findings.
In general, more research is required to evaluate DBAS-
10 among different subcultures and age groups in Iran. It
would be helpful for future studies to use objective mea-
sures such as polysomnography and actigraphy in addi-
tion to self-report measures. Further studies are needed to
retest the relationship between gender and dysfunctional
beliefs about sleep, and reveal the sources of theses gender
differences.
5.2. Conclusions
The current study examined an abbreviated version of
DBAS in a different culture and language, and indicated
promising psychometric properties with regard to relia-
bility and validity. The validation of common sleep instru-
ments is essential to move forward the field of insomnia in
Iran. It is hoped that the validation of the Persian version
encourages Iranian clinicians and researchers to use it dur-
ing assessment and treatment, and facilitate the compari-
son of different studies in this filed.
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